Schizophrenia Research
Volume 88, Issue 1 , Pages 55-62 , December 2006

Substance abuse in first-episode non-affective psychosis

  • Tor K. Larsen

      Affiliations

    • Stavanger University Hospital, Division for Psychiatry, Norway
    • Corresponding Author InformationCorresponding author. Psychiatric Clinic, Stavanger University Hospital, Armauer Hansensv. 20, P. Box 8100 N-4068 Stavanger, Norway. Tel.: +47 51 51 51 51; fax: +47 51 51 50 50.
    • ,
  • Ingrid Melle

      Affiliations

    • Ullevaal University Hospital, Norway
    • ,
  • Bjørn Auestad

      Affiliations

    • Faculty of Science and Technology, University of Stavanger, Norway
    • ,
  • Svein Friis

      Affiliations

    • Ullevaal University Hospital, Norway
    • ,
  • Ulrik Haahr

      Affiliations

    • Roskilde County Psychiatric Hospital Fjorden, Roskilde, Denmark
    • ,
  • Jan Olav Johannessen

      Affiliations

    • Stavanger University Hospital, Division for Psychiatry, Norway
    • ,
  • Stein Opjordsmoen

      Affiliations

    • Ullevaal University Hospital, Norway
    • ,
  • Bjørn Rishovd Rund

      Affiliations

    • Department of Psychology, Oslo, Norway
    • ,
  • Erik Simonsen

      Affiliations

    • Roskilde County Psychiatric Hospital Fjorden, Roskilde, Denmark
    • ,
  • Per Vaglum

      Affiliations

    • The Departments of Behavioral Sciences in Medicine, University of Oslo, Norway
    • ,
  • Thomas H. McGlashan

      Affiliations

    • Department of Psychiatry, Yale University, New Haven, USA

Received 31 March 2006 ,Revised 19 July 2006 ,Accepted 23 July 2006.

References 

  1. Addington J, Williams J, Young J, Addington D. Suicidal behaviour in early psychosis. Acta Psychiatr. Scand. 2004;109:116–120
  2. Amercian Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4 edn.. Washington DC: APA; 1994;
  3. Arndt S, Tyrrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol. Med. 1992;22:379–388
  4. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry. 2004;184:110–117
  5. Buhler B, Hambrecht M, Loffler W, an der HW, Hafner H. Precipitation and determination of the onset and course of schizophrenia by substance abuse—a retrospective and prospective study of 232 population-based first illness episodes. Schizophr. Res. 2002;54:243–251
  6. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982;8:470–484
  7. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res. 2001;48:69–82
  8. Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley I, et al. Prevalence of substance misuse in first-episode psychosis. Br. J. Psychiatry. 1999;174:150–153
  9. Carey KB, Carey MP, Simons JS. Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status. J. Nerv. Ment. Dis. 2003;191:300–308
  10. DeLisi LE, Boccio AM, Riordan H, Hoff AL, Dorfman A, McClelland J, et al. Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Res. 1991;38:39–50
  11. Friis S, Larsen TK, Melle I, Opjordsmoen S, Johannessen JO, Haahr U, et al. Methodological pitfalls in early detection studies—the NAPE Lecture 2002. Nordic Association for Psychiatric Epidemiology. Acta Psychiatr. Scand. 2003;107:3–9
  12. Friis S, Melle I, Larsen TK, Haahr U, Johannessen JO, Simonsen E, et al. Does duration of untreated psychosis bias study samples of first-episode psychosis?. Acta Psychiatr. Scand. 2004;110:286–291
  13. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biol. Psychiatry. 1996;40:1155–1163
  14. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd edn.. New York: Wiley; 2002;
  15. Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs. 2002;62:743–755
  16. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  17. Lambert M, Conus P, Lubman DI, Wade D, Yuen H, Moritz S, et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr. Scand. 2005;112:141–148
  18. Larsen TK, McGlashan TH, Johannessen JO, Vibe-Hansen L. First-episode schizophrenia: II. Premorbid patterns by gender. Schizophr. Bull. 1996;22:257–269
  19. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia: I. Early course parameters. Schizophr. Bull. 1996;22:241–256
  20. Larsen TK, McGlashan TH, Johannessen JO, Friis S, Guldberg C, Haahr U, et al. Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am. J. Psychiatry. 2001;158:1917–1919
  21. Larsen TK, Friis S, Haahr U, Johannessen JO, Melle I, Opjordsmoen S, et al. Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course. Br. J. Psychiatry. 2004;185:108–115
  22. Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch. Gen. Psychiatry. 2004;61:143–150
  23. Mueser KT, Noordsy DL, Drake RE, Fox L. Integrated Treatment for Dual Disorders. New York: The Guilford Press; 2003;
  24. Norwegian Institute for Alcohol and Drug Research (SIRUS) . Assessment of drug abuse in adolescents in Norway 2004. 2004;Ref Type: Report
  25. Rabinowitz J, Bromet EJ, Lavelle J, Carlson G, Kovasznay B, Schwartz JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol. Med. 1998;28:1411–1419
  26. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511–2518
  27. Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH, et al. Sudden death in psychiatric patients. Br. J. Psychiatry. 1998;172:331–336
  28. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID): I. History, rationale, and description. Arch. Gen. Psychiatry. 1992;49:624–629
  29. SPSS for Windows. [11.5.1]. 2001. Chicago, SPSS inc. Ref Type: Computer Program.
  30. Stirling J, Lewis S, Hopkins R, White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr. Res. 2005;75:135–137
  31. Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch. Gen. Psychiatry. 1974;31:37–42
  32. Van Mastrigt S, Addington J, Addington D. Substance misuse at presentation to an early psychosis program. Soc. Psychiatry Psychiatr. Epidemiol. 2004;39:69–72
  33. Verma SK, Subramaniam M, Chong SA, Kua EH. Substance abuse in schizophrenia. A Singapore perspective. Soc. Psychiatry Psychiatr Epidemiol. 2002;37:326–328
  34. Walkup JT, McAlpine DD, Olfson M, Labay L, Boyer CA, Hansell S. Is the substance abuse of inpatients with schizophrenia overlooked?. Gen. Hosp. Psych. 2001;23:26–30
  35. Wallace C, Mullen PE, Burgess P. Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am. J. Psychiatry. 2004;161:716–727

PII: S0920-9964(06)00328-8

doi: 10.1016/j.schres.2006.07.018

Schizophrenia Research
Volume 88, Issue 1 , Pages 55-62 , December 2006

Article Tools